Multivariate analysis of variables correlated with various clinical endpoints
End-point | Factors | HR | 95% CI | P value |
DFS | Age (<50 years vs ≥50 years) | 1.013 | 1.002 to 1.024 | 0.018 |
T stage (T1–2 vs T3–4) | 1.040 | 0.882 to 1.227 | 0.642 | |
N stage (N0–1 vs N2–3) | 1.490 | 1.134 to 1.958 | 0.004 | |
Clinical stage (Ⅰ–Ⅱ vs Ⅲ–Ⅳb) | 1.031 | 1.017 to 1.045 | 0.000 | |
Histology (WHO Ⅱ vs WHO Ⅲ) | 2.025 | 1.358 to 3.020 | 0.001 | |
Tumour volume (<23 mL vs ≥23 mL) | 3.025 | 1.277 to 7.167 | 0.012 | |
CNN (no vs yes) | 1.225 | 0.967 to 1.553 | 0.093 | |
LDH (≤174 IU/L vs >174 IU/L) | 1.669 | 1.110 to 2.921 | 0.014 | |
AC (no vs yes) | 0.870 | 0.641 to 1.180 | 0.370 | |
OS | Age (<50 years versus ≥50 years) | 1.823 | 1.328 to 2.502 | 0.000 |
T stage (T1–2 vs T3–4) | 1.117 | 0.921 to 1.355 | 0.260 | |
N stage (N0–1 vs N2-–3) | 1.276 | 1.004 to 1.618 | 0.043 | |
Clinical stage (Ⅰ–Ⅱ vs Ⅲ–Ⅳb) | 1.163 | 0.881 to 1.534 | 0.287 | |
Histology (WHO Ⅱ vs WHO Ⅲ) | 0.690 | 0.504 to 0.932 | 0.016 | |
CNN (no vs yes) | 2.191 | 1.038 to 4.625 | 0.040 | |
Anaemia (no vs yes) | 0.573 | 0.378 to 0.868 | 0.009 | |
Concurrent chemotherapy (no vs yes) | 0.810 | 0.617 to 1.064 | 0.130 | |
IC (no vs yes) | 1.158 | 0.978 to 1.371 | 0.089 | |
AC (no vs yes) | 1.484 | 0.990 to 2.222 | 0.056 | |
DMFS | N stage (N0–1 vs N2–3) | 2.397 | 1.627 to 3.531 | 0.000 |
Clinical stage (Ⅰ–Ⅱ vs Ⅲ–Ⅳb) | 1.185 | 0.990 to 1.419 | 0.064 | |
Histology (WHOⅡ vs WHO Ⅲ) | 0.654 | 0.412 to 1.037 | 0.071 | |
Tumour volume(<23 mL vs ≥23 mL) | 1.113 | 0.931 to 1.330 | 0.241 | |
CNN (no vs yes) | 1.210 | 1.013 to 1.444 | 0.036 | |
EBV-DNA copy number (<5000 copy/mL vs ≥5000 copy/mL) | 1.183 | 0.965 to 1.448 | 0.105 | |
Anaemia (no vs yes) | 1.116 | 0.881 to 1.415 | 0.362 | |
Concurrent chemotherapy (no vs yes) | 0.816 | 0.599 to 1.111 | 0.197 | |
LRFS | CNN (no vs yes) | 0.930 | 0.521 to 1.660 | 0.806 |
AC (no vs yes) | 1.296 | 0.773 to 2.172 | 0.326 | |
RRFS | IC (no vs yes) | 0.946 | 0.198 to 4.519 | 0.944 |
AC, adjuvant chemotherapy; CNN, cervical nodal necrosis; DFS, disease-free survival; DMFS, distant metastasis-free survival; IC, induction chemotherapy; LDH, lactic dehydrogenase; LRFS, local relapse-free survival; OS, overall survival; RRFS, regional relapse-free survival.